Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Nobias Therapeutics logo — Clinical-stage company developing novel small molecule thera...

Nobias Therapeutics

Clinical-stage company developing novel small molecule therapeutics for rare diseases

Founded 2020 United States Philadelphia, United States 12 employees Series A Total: $3.75M Health Care, Health and Wellness

General Information

Company Name Nobias Therapeutics
Founded Year 2020
Location United States Philadelphia, United States +1
Founders / Decision Makers
Team member
Employees 12
Industries Health Care, Health and Wellness
Funding Stage Series A
Social

Get notified when Nobias Therapeutics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Nobias Therapeutics

Nobias Therapeutics is an AI-first therapeutics company founded in 2020, with a focus on the health care sector. The company is currently engaged in a phase 2 clinical trial aimed at addressing symptoms of anxiety, inattention, and autism in children with 22q11 deletion syndrome. Nobias has recently secured a significant $3.75M Series A investment on 24 July 2020, with Domain Associates as the lead investor. This funding is poised to support the company's mission of leveraging AI to revolutionize therapeutic interventions. With its innovative approach and strong backing, Nobias Therapeutics is shaping up to be a significant player in the biotech space.

Taxonomy: AI-first, therapeutics, clinical trial, anxiety treatment, attention treatment, autism treatment, pediatric therapies, 22q11 deletion syndrome, phase 2, drug development, neurobehavioral disorders

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Series A •••••• 1
Investor
24 Jul 2020

Nobias Therapeutics Alternatives & Competitors

Nobias Therapeutics vs
RELIEF THERAPEUTICS Holding SA
RELIEF THERAPEUTICS Holding SA Switzerland

Providing relief to patients with unmet medical needs in select specialty and rare diseases.

Post Ipo Equity
9 employees
Biotechnology, Pharmaceutical
Nobias Therapeutics vs
AUG Therapeutics, LLC
AUG Therapeutics, LLC

AUG Therapeutics is a clinical-stage biotechnology company specializing in the acquisition and devel...

2 employees
Biotechnology, Health Care
Nobias Therapeutics vs
Avalo Therapeutics
Avalo Therapeutics United States

Innovation driven by compassion.

Post Ipo Equity
48 employees
Biotechnology, Health and Wellness

FAQ About Nobias Therapeutics

Clinical-stage company developing novel small molecule therapeutics for rare diseases
Nobias Therapeutics was founded in 2020.
Nobias Therapeutics is headquartered in Philadelphia, United States.
Nobias Therapeutics operates in the following industries: Health Care, Health and Wellness.
Nobias Therapeutics has approximately 12 employees.
Nobias Therapeutics has completed 1 funding round, raising a total of $3.75M. The latest funding stage is Series A.
Top alternatives and competitors to Nobias Therapeutics include RELIEF THERAPEUTICS Holding SA, AUG Therapeutics, LLC, Avalo Therapeutics, Revive Therapeutics Ltd. CSE: RVV | USA: RVVTF, Ultragenyx Pharmaceutical Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Nobias Therapeutics and RELIEF THERAPEUTICS Holding SA are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Nobias Therapeutics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes